European Medical Solutions
XBRU:ALEMS
Cash Flow Statement
Cash Flow Statement
European Medical Solutions
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(1)
|
(0)
|
(0)
|
(0)
|
(6)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
|
| Depreciation & Amortization |
0
|
0
|
2
|
3
|
4
|
3
|
4
|
4
|
2
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
0
|
0
|
(1)
|
3
|
0
|
0
|
0
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Change in Working Capital |
(1)
|
(1)
|
(1)
|
(3)
|
1
|
(2)
|
(1)
|
2
|
(0)
|
(2)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+36%
|
0
N/A
|
(2)
N/A
|
2
N/A
|
1
-71%
|
(2)
N/A
|
1
N/A
|
3
+104%
|
2
-13%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
0
|
0
|
(2)
|
0
|
(2)
|
(4)
|
(3)
|
(3)
|
(4)
|
(3)
|
|
| Other Items |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
|
| Cash from Investing Activities |
1
N/A
|
1
+14%
|
(1)
N/A
|
1
N/A
|
(1)
N/A
|
(3)
-222%
|
(1)
+54%
|
(2)
-42%
|
(3)
-38%
|
(2)
+20%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
0
|
3
|
4
|
0
|
(1)
|
3
|
(0)
|
1
|
2
|
|
| Other |
(0)
|
(0)
|
(1)
|
(4)
|
0
|
3
|
0
|
0
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
(0)
N/A
|
(0)
+44%
|
2
N/A
|
0
-76%
|
0
-1%
|
2
+369%
|
3
+58%
|
(0)
N/A
|
1
N/A
|
1
+34%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(1)
N/A
|
(0)
+77%
|
1
N/A
|
(0)
N/A
|
2
N/A
|
(0)
N/A
|
0
N/A
|
(1)
N/A
|
0
N/A
|
1
+127%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
+36%
|
(2)
-80%
|
(2)
-6%
|
0
N/A
|
(3)
N/A
|
(4)
-51%
|
(2)
+54%
|
(1)
+50%
|
(1)
+17%
|
|